Clinical Trial Update: CP-690-550 Ointment For Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CP-690-550 ointment in chronic plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• CP-690-550 ointment

Snippet

Sponsor: Pfizer | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-11